Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06329557 · ClinicalTrials.gov registry record · NA
Optimizing the Patient Experience Through Provider Coaching or Communication Intervention
A NA study of Communication and Patient Satisfaction, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 2
- Study locations
NCT06329557: Active NA study of Communication and Patient Satisfaction, sponsored by Mayo Clinic.
NCT06329557 is a NA study of Communication and Patient Satisfaction that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 45 participants, below the 1,420-participant average among 34 other Communication trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06329557, a NA study of Communication and Patient Satisfaction, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
Hypothesis: Clinicians who receive patient experience coaching or communication classes have improved patient satisfaction scores and improved clinician satisfaction.
Primary Outcome
Participants will be sent a Pre-test Questionnaire and Maslach Burnout Inventory within the introductory email containing a RedCap link for them to use if they desire to participate. Immediately following the intervention, and two months after the intervention, participants will receive a Maslach Burnout Inventory to complete. Method used: Average Emotional Exhaustion- Higher the scores indicate higher degree of burnout Depersonalization- Higher scores indicate higher degree of burnout Persona
Conditions Studied
Interventions
- BEHAVIORAL Intervention 1
Study Locations (2)
Minnesota
- Mayo Clinic in Rochester - Rochester
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2024-03-08 |
| Est. Completion | 2026-03-09 |
| Phase | NA |
What the registry record for NCT06329557 still lists
NCT06329557 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,420-participant average among 34 other Communication trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Communication appearing as the primary indexed condition, and to 1 intervention - of which Intervention 1 is the first listed.
NCT06329557 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06329557 about?
NCT06329557 is a clinical study titled "Optimizing the Patient Experience Through Provider Coaching or Communication Intervention". Hypothesis: Clinicians who receive patient experience coaching or communication classes have improved patient satisfaction scores and improved clinician satisfaction.
What is the current status of trial NCT06329557?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2024-03-08. Estimated completion is 2026-03-09.
What conditions does trial NCT06329557 study?
This clinical trial studies the following conditions: Communication, Patient Satisfaction.
What interventions are being tested in trial NCT06329557?
The interventions under investigation include: Intervention 1 (BEHAVIORAL).
Who is sponsoring clinical trial NCT06329557?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06329557 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Communication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06329557's enrollment target sits among peer trials
45 32nd of 34 higher than 3 of 34 other Communication trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Communication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Seminar in Unwavering Empowering Presence Optimized for Rehabilitation Teams
RECRUITING · NA
-
Communication Strategies to Increase HPV Vaccination Intention
RECRUITING · NA
-
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RECRUITING · NA
-
Alcohol and Sexual Communication Among Couples in the Laboratory
RECRUITING · NA
-
Families of Youth with Developmental Disabilities: a Theory-Based Intervention
RECRUITING · NA
-
Timing of Physician Rounds for Antepartum Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI